• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Ex­clu­sive: Start­up rais­es $45M for uni­ver­sal flu vac­cines made with mR­NA

Yesterday
Startups
R&D

Shell com­pa­ny Con­cen­tra has found its rhythm, with Car­go Ther­a­peu­tics as its lat­est buy­out tar­get

Yesterday
Deals
Cell/Gene Tx

Sin­ga­pore­an biotech gets Chi­na thumbs-up for study of po­ten­tial­ly cu­ra­tive HBV cell ther­a­py

Yesterday
R&D
China

No­var­tis maps launch of malar­ia drug for new­borns af­ter Swiss ap­proval

Yesterday
Pharma

Clin­i­cian groups sue RFK Jr. and HHS over Covid-19 vac­cine rec­om­men­da­tion changes

2 days ago
R&D
Pharma

Trump's tax cut law ex­pands or­phan drug ex­clu­sions, could up­end 340B pro­gram

2 days ago
Pharma
Law

The Supreme Court passed on a state PBM case. Lawyers say a broad­er le­gal fight is brew­ing

2 days ago
Pharma
Law

KalVista CEO says FDA re­view pro­ceed­ed nor­mal­ly, was un­aware of Makary's re­jec­tion ask

2 days ago
People
Pharma

FDA chief calls for 'mean­ing­ful' re­duc­tion of an­i­mal test­ing for new drugs

2 days ago
FDA+

Health tech star­tups raise $6.4B in first half of 2025 in AI fren­zy

2 days ago
Financing
Health Tech

Co­gent’s mas­to­cy­to­sis drug hits ‘home run’ in reg­is­tra­tional mid-stage tri­al

2 days ago
R&D

De­nal­i's Hunter syn­drome ther­a­py gets pri­or­i­ty re­view; LENZ inks Cana­da deal

2 days ago
News Briefing

Com­pro­mised drug lot im­pacts Jasper's chron­ic hives study, stock falls

2 days ago
R&D
Manufacturing

Apogee re­ports Phase 2 win for eczema drug that could chal­lenge Dupix­ent and Ebglyss

2 days ago
R&D

De­spite de­lay, KalVista wins FDA ap­proval af­ter Makary's short-lived at­tempt to in­ter­vene

2 days ago
Pharma

Roche-backed Chugai taps in­to longevi­ty field with Pfiz­er-al­lied Gero

2 days ago
Startups
Deals

Eu­ro­pean Com­mis­sion fines Alchem, clos­es API ‘car­tel’ in­ves­ti­ga­tion 

2 days ago
Manufacturing
Law

Ap­ple Tree says its biotechs face ‘im­mi­nent col­lapse’; Ad­vo­cates urge J&J to pro­ceed with eye gene ther­a­py; ...

4 days ago
Weekly

HHS ac­tions to re­move web con­tent were ar­bi­trary, 'poor­ly thought-through,' judge rules

6 days ago
Pharma
Law

No­var­tis' Cosen­tyx fails Phase 3 study for au­toim­mune dis­ease

6 days ago
R&D
Pharma

Cloud­break’s shares stum­ble in Hong Kong de­but; Sino­vac squares off against ac­tivist

6 days ago
News Briefing

Tor­rent Phar­ma’s $1.38B JB Chem­i­cals takeover; Fu­ture Pak to buy Ther­at­e­ch­nolo­gies

6 days ago
Manufacturing

The Trump ad­min­is­tra­tion is pro­mot­ing wear­able health de­vices — with or with­out ev­i­dence

6 days ago
Pharma
Health Tech

Num­ber of megarounds drops 38% in first half as biotechs strug­gle against wors­en­ing slump

6 days ago
Financing
Startups
First page Previous page 12345 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times